Dossier
Michael Severino
Coverage of Michael Severino in the Nexus archive.
- STAT+: Sarepta names Michael Severino, former Tessera CEO, as new chief executive
Sarepta Therapeutics appointed Michael Severino, formerly CEO of Tessera Therapeutics, as its new chief executive. The company, which has three Duchenne muscular dystrophy treatments approved, faces ongoing questions about their effectiveness and regulatory scrutiny over gene therapy safety, contributing to a decline in its share price.